RNAi technology to block the expression of molecules relevant to metastasis: the cell adhesion molecule CEACAM1 as an

Daniel Wicklein1

  • 1Centre for Experimental Medicine, Institute for Anatomy and Experimental Morphology, Hamburg, Germany. d.wicklein@uke.uni-hamburg.de

Insights

Researchers silenced the CEACAM1 gene in melanoma cells using small hairpin RNA (shRNA). This stable gene silencing effectively reduced CEACAM1 expression, aiding cancer metastasis research.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The metastatic process in cancer is complex and influenced by various cellular factors.
  • Cellular adhesion molecules, such as CEACAM1, play a potential role in tumor formation and metastasis.
  • Investigating specific gene functions is crucial for understanding cancer progression.

Purpose of the Study:

  • To investigate the role of the cellular adhesion molecule CEACAM1 in melanoma metastasis.
  • To develop a stable melanoma cell line with reduced CEACAM1 expression for research purposes.

Main Methods:

  • Utilized small hairpin RNA (shRNA) constructs for specific gene silencing of CEACAM1.
  • Transfected the human melanoma cell line FemX-1 with CEACAM1-directed shRNA.
  • Obtained and characterized stable cell clones using puromycin selection, single-cell dilution, and FACS analysis.
  • Validated CEACAM1 knockdown stability in an SCID mouse xenograft model.

Main Results:

  • Achieved a stable CEACAM1 knockdown of over 85% in the transfected FemX-1 melanoma cell line.
  • The observed gene silencing remained stable for at least 40 days in vivo within an SCID mouse xenograft model.
  • Successfully generated a characterized cell line for studying CEACAM1's function in metastasis.

Conclusions:

  • Specific gene silencing of CEACAM1 using shRNA is a viable method for cancer research.
  • The developed melanoma cell line with stable CEACAM1 knockdown provides a valuable tool for investigating its role in metastasis.
  • Further studies can utilize this model to elucidate the precise mechanisms by which CEACAM1 influences tumor formation and spread.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...